This filing is a routine marketing/promotional event with no material financial data. Traders should monitor future 10-Q filings for any revenue traction or reimbursement updates for CyPath Lung, but no immediate trading action is warranted.
Price Chart
Executive Summary
bioAffinity Technologies announced via an 8-K that the Society for Advanced Bronchoscopy will host a webinar on June 16, 2026, featuring a multidisciplinary physician panel discussing the real-world use of the company's CyPath Lung test for early-stage lung cancer detection and management. This is a routine educational and marketing event with no financial data, guidance, or material business developments disclosed.
Key Facts
- Webinar titled 'Navigating Lower Cancer-Risk Nodules in High-Risk Patients with Noninvasive CyPath Lung Testing' scheduled for June 16, 2026 at 7 p.m. ET.
- Panel includes an interventional pulmonologist, medical oncologist, and thoracic surgeon.
- CyPath Lung is a noninvasive test using flow cytometry and AI, marketed as a Laboratory Developed Test (LDT).
- No financial figures, revenue data, guidance, or material agreements were disclosed in the filing.
Financial Impact
No financial impact disclosed; the filing is a routine educational event announcement.
Risk Factors
- CyPath Lung is marketed as an LDT and faces regulatory uncertainty regarding FDA oversight of LDTs.
- No disclosed revenue or adoption metrics — commercial traction remains unquantified.
- Company has a micro-cap market cap ($1M) with limited liquidity and high volatility risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026773 |
| Exhibit: ex99-1.htm | 0001493152-26-026773 |
| Document: 0001493152-26-026773-index-headers.html | 0001493152-26-026773 |
| Document: 0001493152-26-026773-index.html | 0001493152-26-026773 |
| Document: 0001493152-26-026773.txt | 0001493152-26-026773 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 2, 2026 20w ago | 8-K | $0.2950 $0.1300 | ▼ −55.93% | ▼ −54.37% | — |
May 27, 2026 21w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▲ +1.90% | — |
May 13, 2026 23w ago | EFFECT | $0.2950 $0.2950 | · 0.00% | ▲ +0.61% | — |
May 12, 2026 23w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▲ +1.73% | — |
May 8, 2026 24w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▼ −0.02% | — |
Apr 14, 2026 27w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▼ −6.30% | — |
Apr 7, 2026 28w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▼ −9.78% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers